NCT01248273
Conditions: Fallopian Tubes, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I



Conditions: Fallopian Tubes, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I
Immunoglobulin and QS-21 in Patients With Follicular Lymphomas
Conditions: Lymphoma
Sponsors: National Cancer Institute (NCI)
Phase I
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I
Conditions: Melanoma
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase n/a
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center. National Cancer Institute (NCI)
Phase n/a
Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase II
Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Conditions: Breast Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I
Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase II
Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I
Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I